EA201992557A1 - ANTITUMOR COMPOUNDS - Google Patents

ANTITUMOR COMPOUNDS

Info

Publication number
EA201992557A1
EA201992557A1 EA201992557A EA201992557A EA201992557A1 EA 201992557 A1 EA201992557 A1 EA 201992557A1 EA 201992557 A EA201992557 A EA 201992557A EA 201992557 A EA201992557 A EA 201992557A EA 201992557 A1 EA201992557 A1 EA 201992557A1
Authority
EA
Eurasian Patent Office
Prior art keywords
antitumor compounds
antitumor
compounds
cancer
compound
Prior art date
Application number
EA201992557A
Other languages
Russian (ru)
Inventor
Мария дель Кармен Куэвас Марчанте
Андрес Франсесч Сольосо
Валентин Мартинес Барраса
Original Assignee
Фарма Мар, С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фарма Мар, С.А. filed Critical Фарма Мар, С.А.
Priority claimed from PCT/EP2018/060868 external-priority patent/WO2018197663A1/en
Publication of EA201992557A1 publication Critical patent/EA201992557A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings

Abstract

Соединение общей формулы I, где X, R-Rимеют разные значения, для применения в лечении рака.The compound of general formula I, where X, R-R have different meanings, for use in the treatment of cancer.

EA201992557A 2017-07-26 2018-04-27 ANTITUMOR COMPOUNDS EA201992557A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17382497 2017-07-26
PCT/EP2018/060868 WO2018197663A1 (en) 2017-04-27 2018-04-27 Antitumoral compounds

Publications (1)

Publication Number Publication Date
EA201992557A1 true EA201992557A1 (en) 2020-02-25

Family

ID=59523042

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201992557A EA201992557A1 (en) 2017-07-26 2018-04-27 ANTITUMOR COMPOUNDS

Country Status (3)

Country Link
CY (1) CY1126035T1 (en)
EA (1) EA201992557A1 (en)
PT (3) PT3615544T (en)

Also Published As

Publication number Publication date
PT4047002T (en) 2023-05-15
CY1126035T1 (en) 2023-11-15
PT3615544T (en) 2023-05-18
PT4101855T (en) 2023-10-13

Similar Documents

Publication Publication Date Title
ZA201906111B (en) Cyclic di-nucleotides compounds for the treatment of cancer
EA201791563A1 (en) SUBSTITUTED NUCLEOSIDE DERIVATIVES, USEFUL AS AN AGENT AGAINST CANCER
PH12018502497A1 (en) Adenosine derivatives for use in the treatment of cancer
GEP20217211B (en) Substituted carbonucleoside derivatives useful as anticancer agents
GEP20186933B (en) Substituted dihydroisoquinoline compounds
NI201800042A (en) NEW DERIVATIVES OF PIRROLO [2,3-D] PYRIMIDINE AS DUAL INHIBITORS OF DYRK1 / CLK1
EA201400178A1 (en) BREAST CANCER TREATMENT
MY197626A (en) Dihydroimidazopyrazinone derivatives useful in the treatment of cancer
EA201790779A1 (en) SUBSTITUTED AMINOPURIN COMPOUNDS, THEIR COMPOSITIONS AND METHODS OF TREATMENT USING SUCH CONNECTIONS
MY198004A (en) Antitumoral compounds
PH12017501879A1 (en) Methods for treating cancer
MX2018010993A (en) Icariin and icaritin derivatives.
MX2018001576A (en) Pyridines and their use in the treatment of cancer.
MX2019001979A (en) PPARy AGONIST FOR TREATMENT OF BLOOD CANCERS.
EA201790687A1 (en) QUINOLINCARBOXAMIDE FOR USE IN THE TREATMENT OF MULTIPLE MYELOMA
MX2018001575A (en) Tricyclic compounds and their use in the treatment of cancer.
EA201992557A1 (en) ANTITUMOR COMPOUNDS
EA201892188A1 (en) PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS
GB2553684A8 (en) Ethynylxanthines, preparation and use for cancer treatment